Abstract | BACKGROUND: METHODS: We measured eIF-5A2 expression and doxorubicin sensitivity in different human breast cancer cell lines (Bcap-1937, HCC1937, and MCF-7). To investigate a role for eIF-5A2 in chemoresistance, cells were treated with eIF-5A2-siRNA, exposed to various concentrations of doxorubicin, and toxicity was assayed by CCK-8 (cell counting kit). RESULTS: CONCLUSION:
|
Authors | Yu Liu, Feiya Du, Wei Chen, Minya Yao, Kezhen Lv, Peifen Fu |
Journal | Breast cancer (Tokyo, Japan)
(Breast Cancer)
Vol. 22
Issue 6
Pg. 602-7
(Nov 2015)
ISSN: 1880-4233 [Electronic] Japan |
PMID | 24638963
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibiotics, Antineoplastic
- Peptide Initiation Factors
- RNA, Small Interfering
- RNA-Binding Proteins
- eukaryotic translation initiation factor 5A
- Doxorubicin
|
Topics |
- Antibiotics, Antineoplastic
(pharmacology)
- Breast Neoplasms
(drug therapy, genetics, pathology)
- Cell Line, Tumor
(drug effects)
- Doxorubicin
(pharmacology)
- Drug Resistance, Neoplasm
(genetics)
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Gene Knockdown Techniques
- Humans
- MCF-7 Cells
(drug effects)
- Peptide Initiation Factors
(genetics, metabolism)
- RNA, Small Interfering
- RNA-Binding Proteins
(genetics, metabolism)
|